-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Upgrades Apyx Medical to Market Outperform, Announces $8 Price Target

Benzinga·11/12/2025 14:13:57
Listen to the news
Citizens analyst David Turkaly upgrades Apyx Medical (NASDAQ:APYX) from Market Perform to Market Outperform and announces $8 price target.